Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Didier Chassard
Observed names:
D CHASSARD,
D Chassard,
D. CHASSARD,
D. Chassard
Institution:
Biotrial (France)
Observed institutions:
ASTER,
Novo Nordisk (Denmark),
Sanofi (France),
Aster,
Hôpital Charles-Nicolle,
Assistance Publique – Hôpitaux de Paris,
Procter & Gamble (Germany),
Biotrial (France),
University of Virginia,
Procter & Gamble (United States),
University of Guyana
show all 11
OpenAlex ID:
A5006933051
Slow release caffeine and prolonged (64‐h) continuous wakefulness: effects on vigilance and cognitive performance
2001
·
M. Beaumont
, D. Batejat
, et al.
·
Journal of Sleep Research
·
119
Skin Sensitivity to Rocuronium and Vecuronium: A Randomized Controlled Prick-Testing Study in Healthy Volunteers
2004
·
Gilles Dhonneur
, Xavier Combes
, et al.
·
Anesthesia & Analgesia
·
65
Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17 -estradiol (NOMAC/E2): a double-blind, randomized study
2011
·
S. Christin-Maitre
, D. Serfaty
, et al.
·
Human Reproduction
·
62
Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea
2000
·
R. Brouard
, T. Bossmar
, et al.
·
BJOG An International Journal of Obstetrics & Gynaecology
·
62
Slow-Release Caffeine: A New Response to the Effects of a Limited Sleep Deprivation
2000
·
Didier Lagarde
, Denise Batéjat
, et al.
·
SLEEP
·
58
A digestive tolerance study of maltitol after occasional and regular consumption in healthy humans
2003
·
A Ruskoné-Fourmestraux
, A Attar
, et al.
·
European Journal of Clinical Nutrition
·
43
Pharmacokinetics of Sparfloxacin in Humans After Single Oral Administration at Doses of 200, 400, 600, and 800 mg
1994
·
G. Montay
, R. Bruno
, et al.
·
The Journal of Clinical Pharmacology
·
38
Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: A double-blind, randomised, dose-finding pilot study
2011
·
Nathalie Chabbert-Buffet
, Didier Chassard
, et al.
·
The European Journal of Contraception & Reproductive Health Care
·
31
Safety and Pharmacokinetics of P792, a New Blood-Pool Agent
2002
·
S. GAILLARD
, C. KUBIAK
, et al.
·
Investigative Radiology
·
31
A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab™ for pre-exposure use in healthy adults: Results from a randomized controlled phase-II trial
2013
·
Sylvie Pichon
, Françoise Guinet-Morlot
, et al.
·
Vaccine
·
26
Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects
2009
·
Alain Patat
, Virginia Parks
, et al.
·
British Journal of Clinical Pharmacology
·
26
PDF
Which bioequivalence study for a racemic drug? Application to milnacipran
1998
·
D. Deprez
, D. Chassard
, et al.
·
European Journal of Drug Metabolism and Pharmacokinetics
·
20
Pharmacokinetics of Repaglinide in Healthy Caucasian and Japanese Subjects
2003
·
M. S. Thomsen
, D. Chassard
, et al.
·
The Journal of Clinical Pharmacology
·
18
The pharmacokinetics of tiopronin and its principal metabolite (2-mercaptopropionic acid) after oral administration to healthy volunteers
1992
·
B. Hercelin
, P. Leroy
, et al.
·
European Journal of Clinical Pharmacology
·
17
Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive
2013
·
Maribel Reyes
, Patrick Brossard
, et al.
·
European Journal of Clinical Pharmacology
·
16
A randomized prospective trial of the cutaneous and sensory effects of feminine hygiene wet wipes.
2008
·
Miranda A Farage
, Angela Stadler
, et al.
·
PubMed
·
15
Comparative Bioavailability Study of Cefixime Administered as Tablets or Aqueous Solution
1991
·
G. Montay
, F. Masala
, et al.
·
Drugs
·
15
Lack of pharmacokinetic interaction when switching from fluoxetine to milnacipran
2006
·
Christian Puozzo
, Philippe Hermann
, et al.
·
International Clinical Psychopharmacology
·
12
A single centre, open‐label, cross‐over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin®) and topical clindamycin lotion (Dalacin® T) in subjects with mild to moderate acne
2006
·
Didier Chassard
, Roo Kanis
, et al.
·
Journal of Dermatological Treatment
·
11
Pharmacokinetic Parameters of Ciprofloxacin (500 mg/5 mL) Oral Suspension in Critically Ill Patients with Severe Bacterial Pneumonia: A Comparison of Two Dosages
2002
·
R. Debon
, D. Breilh
, et al.
·
Journal of Chemotherapy
·
11
Activité antigonadotrope de l'acétate de chlormadinone chez la femme en période d'activité génitale
2005
·
D. Chassard
, B. Schatz
·
Gynécologie Obstétrique & Fertilité
·
9
Bioequivalence Study of Two Ibuprofen Formulations Administered Intravenously in Healthy Male Volunteers
2004
·
D Chassard
, A Geneteau
, et al.
·
Clinical Drug Investigation
·
9
Investigation of the impact of sarizotan on the pharmacokinetics of levodopa
2007
·
Sonja Krösser
, Roland Neugebauer
, et al.
·
Biopharmaceutics & Drug Disposition
·
8
[Leukocytoclastic vasculitis after injection of low-molecular-weight heparin (letter)].
2000
·
B de Bats
, L Rivard
, et al.
·
PubMed
·
8
Etude de la biodisponibilité relative de deux formulations orales d’acétate de chlormadinone : Lutéran® 5 mg et Lutéran® comprimé dosé à 10 mg
2003
·
Didier Chassard
, Pascale Legallicier
, et al.
·
Therapies
·
6
Show more works
View as search
Works count:
52
Citation count:
764
H-index:
15
I10-index:
20
Year
Topic
Type